Folate-related polymorphisms in gastrointestinal stromal tumours

susceptibility and correlation with tumour characteristics and clinical outcome

Sabrina Angelini, Gloria Ravegnini, Margherita Nannini, Justo Lorenzo Bermejo, Muriel Musti, Maria A. Pantaleo, Elena Fumagalli, Nicola Venturoli, Elena Palassini, Nicola Consolini, Paolo G. Casali, Guido Biasco, Patrizia Hrelia

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The folate metabolism pathway has a crucial role in tumorigenesis as it supports numerous critical intracellular reactions, including DNA synthesis, repair, and methylation. Despite its importance, little is known about the influence of the folate pathway on gastrointestinal stromal tumour (GIST), a rare tumour with an incidence ranging between 6 and 19.6 cases per million worldwide. The importance of folate metabolism led us to investigate the influence of polymorphisms in the genes coding folate-metabolising enzymes on GIST susceptibility, tumour characteristics and clinical outcome. We investigated a panel of 13 polymorphisms in 8 genes in 60 cases and 153 controls. The TS 6-bp deletion allele (formerly rs34489327, delTInsTTAAAG) was associated with reduced risk of GIST (OR=0.20, 95% CI 0.05-0.67, P=0.0032). Selected polymorphisms in patients stratified by age, gender, and other main molecular and clinical characteristics showed that few genotypes may show a likely correlation. We also observed a significant association between the RFC AA/AG genotype and time to progression (HR=0.107, 95% CI 0.014-0.82; P=0.032). Furthermore, we observed a tendency towards an association between the SHMT1 variant allele (TT, rs1979277) and early death (HR=4.53, 95% CI 0.77-26.58, P=0.087). Aware of the strengths and limitations of the study, these results suggest that polymorphisms may modify the risk of GIST and clinical outcome, pointing to the necessity for further investigations with information on folate plasma levels and a larger study population.

Original languageEnglish
Pages (from-to)817-823
Number of pages7
JournalEuropean Journal of Human Genetics
Volume23
Issue number6
DOIs
Publication statusPublished - Jun 15 2015

Fingerprint

Gastrointestinal Stromal Tumors
Folic Acid
Neoplasms
Alleles
Genotype
DNA Methylation
DNA Repair
Genes
Carcinogenesis
Incidence
Enzymes
Population

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Folate-related polymorphisms in gastrointestinal stromal tumours : susceptibility and correlation with tumour characteristics and clinical outcome. / Angelini, Sabrina; Ravegnini, Gloria; Nannini, Margherita; Bermejo, Justo Lorenzo; Musti, Muriel; Pantaleo, Maria A.; Fumagalli, Elena; Venturoli, Nicola; Palassini, Elena; Consolini, Nicola; Casali, Paolo G.; Biasco, Guido; Hrelia, Patrizia.

In: European Journal of Human Genetics, Vol. 23, No. 6, 15.06.2015, p. 817-823.

Research output: Contribution to journalArticle

Angelini, Sabrina ; Ravegnini, Gloria ; Nannini, Margherita ; Bermejo, Justo Lorenzo ; Musti, Muriel ; Pantaleo, Maria A. ; Fumagalli, Elena ; Venturoli, Nicola ; Palassini, Elena ; Consolini, Nicola ; Casali, Paolo G. ; Biasco, Guido ; Hrelia, Patrizia. / Folate-related polymorphisms in gastrointestinal stromal tumours : susceptibility and correlation with tumour characteristics and clinical outcome. In: European Journal of Human Genetics. 2015 ; Vol. 23, No. 6. pp. 817-823.
@article{1475ea39a52842b6b4dfb2ca92223022,
title = "Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome",
abstract = "The folate metabolism pathway has a crucial role in tumorigenesis as it supports numerous critical intracellular reactions, including DNA synthesis, repair, and methylation. Despite its importance, little is known about the influence of the folate pathway on gastrointestinal stromal tumour (GIST), a rare tumour with an incidence ranging between 6 and 19.6 cases per million worldwide. The importance of folate metabolism led us to investigate the influence of polymorphisms in the genes coding folate-metabolising enzymes on GIST susceptibility, tumour characteristics and clinical outcome. We investigated a panel of 13 polymorphisms in 8 genes in 60 cases and 153 controls. The TS 6-bp deletion allele (formerly rs34489327, delTInsTTAAAG) was associated with reduced risk of GIST (OR=0.20, 95{\%} CI 0.05-0.67, P=0.0032). Selected polymorphisms in patients stratified by age, gender, and other main molecular and clinical characteristics showed that few genotypes may show a likely correlation. We also observed a significant association between the RFC AA/AG genotype and time to progression (HR=0.107, 95{\%} CI 0.014-0.82; P=0.032). Furthermore, we observed a tendency towards an association between the SHMT1 variant allele (TT, rs1979277) and early death (HR=4.53, 95{\%} CI 0.77-26.58, P=0.087). Aware of the strengths and limitations of the study, these results suggest that polymorphisms may modify the risk of GIST and clinical outcome, pointing to the necessity for further investigations with information on folate plasma levels and a larger study population.",
author = "Sabrina Angelini and Gloria Ravegnini and Margherita Nannini and Bermejo, {Justo Lorenzo} and Muriel Musti and Pantaleo, {Maria A.} and Elena Fumagalli and Nicola Venturoli and Elena Palassini and Nicola Consolini and Casali, {Paolo G.} and Guido Biasco and Patrizia Hrelia",
year = "2015",
month = "6",
day = "15",
doi = "10.1038/ejhg.2014.198",
language = "English",
volume = "23",
pages = "817--823",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Folate-related polymorphisms in gastrointestinal stromal tumours

T2 - susceptibility and correlation with tumour characteristics and clinical outcome

AU - Angelini, Sabrina

AU - Ravegnini, Gloria

AU - Nannini, Margherita

AU - Bermejo, Justo Lorenzo

AU - Musti, Muriel

AU - Pantaleo, Maria A.

AU - Fumagalli, Elena

AU - Venturoli, Nicola

AU - Palassini, Elena

AU - Consolini, Nicola

AU - Casali, Paolo G.

AU - Biasco, Guido

AU - Hrelia, Patrizia

PY - 2015/6/15

Y1 - 2015/6/15

N2 - The folate metabolism pathway has a crucial role in tumorigenesis as it supports numerous critical intracellular reactions, including DNA synthesis, repair, and methylation. Despite its importance, little is known about the influence of the folate pathway on gastrointestinal stromal tumour (GIST), a rare tumour with an incidence ranging between 6 and 19.6 cases per million worldwide. The importance of folate metabolism led us to investigate the influence of polymorphisms in the genes coding folate-metabolising enzymes on GIST susceptibility, tumour characteristics and clinical outcome. We investigated a panel of 13 polymorphisms in 8 genes in 60 cases and 153 controls. The TS 6-bp deletion allele (formerly rs34489327, delTInsTTAAAG) was associated with reduced risk of GIST (OR=0.20, 95% CI 0.05-0.67, P=0.0032). Selected polymorphisms in patients stratified by age, gender, and other main molecular and clinical characteristics showed that few genotypes may show a likely correlation. We also observed a significant association between the RFC AA/AG genotype and time to progression (HR=0.107, 95% CI 0.014-0.82; P=0.032). Furthermore, we observed a tendency towards an association between the SHMT1 variant allele (TT, rs1979277) and early death (HR=4.53, 95% CI 0.77-26.58, P=0.087). Aware of the strengths and limitations of the study, these results suggest that polymorphisms may modify the risk of GIST and clinical outcome, pointing to the necessity for further investigations with information on folate plasma levels and a larger study population.

AB - The folate metabolism pathway has a crucial role in tumorigenesis as it supports numerous critical intracellular reactions, including DNA synthesis, repair, and methylation. Despite its importance, little is known about the influence of the folate pathway on gastrointestinal stromal tumour (GIST), a rare tumour with an incidence ranging between 6 and 19.6 cases per million worldwide. The importance of folate metabolism led us to investigate the influence of polymorphisms in the genes coding folate-metabolising enzymes on GIST susceptibility, tumour characteristics and clinical outcome. We investigated a panel of 13 polymorphisms in 8 genes in 60 cases and 153 controls. The TS 6-bp deletion allele (formerly rs34489327, delTInsTTAAAG) was associated with reduced risk of GIST (OR=0.20, 95% CI 0.05-0.67, P=0.0032). Selected polymorphisms in patients stratified by age, gender, and other main molecular and clinical characteristics showed that few genotypes may show a likely correlation. We also observed a significant association between the RFC AA/AG genotype and time to progression (HR=0.107, 95% CI 0.014-0.82; P=0.032). Furthermore, we observed a tendency towards an association between the SHMT1 variant allele (TT, rs1979277) and early death (HR=4.53, 95% CI 0.77-26.58, P=0.087). Aware of the strengths and limitations of the study, these results suggest that polymorphisms may modify the risk of GIST and clinical outcome, pointing to the necessity for further investigations with information on folate plasma levels and a larger study population.

UR - http://www.scopus.com/inward/record.url?scp=84929295814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929295814&partnerID=8YFLogxK

U2 - 10.1038/ejhg.2014.198

DO - 10.1038/ejhg.2014.198

M3 - Article

VL - 23

SP - 817

EP - 823

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 6

ER -